Fisher & Paykel Healthcare (NZSE:FPH) Days Sales Outstanding : 46.72 (As of Sep. 2023)

View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare Days Sales Outstanding?

Fisher & Paykel Healthcare's average Accounts Receivable for the six months ended in Sep. 2023 was NZ$209 Mil. Fisher & Paykel Healthcare's Revenue for the six months ended in Sep. 2023 was NZ$816 Mil. Hence, Fisher & Paykel Healthcare's Days Sales Outstanding for the six months ended in Sep. 2023 was 46.72.

The historical rank and industry rank for Fisher & Paykel Healthcare's Days Sales Outstanding or its related term are showing as below:

NZSE:FPH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 36.81 Med: 46.97 Max: 51.76
Current: 43.82

During the past 13 years, Fisher & Paykel Healthcare's highest Days Sales Outstanding was 51.76. The lowest was 36.81. And the median was 46.97.

NZSE:FPH's Days Sales Outstanding is ranked better than
78.69% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 63.94 vs NZSE:FPH: 43.82

Fisher & Paykel Healthcare's Days Sales Outstanding increased from Sep. 2022 (45.46) to Sep. 2023 (46.72).

Fisher & Paykel Healthcare Days Sales Outstanding Historical Data

The historical data trend for Fisher & Paykel Healthcare's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Days Sales Outstanding Chart

Fisher & Paykel Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

45.06

47.62

36.81

38.31

38.17

Fisher & Paykel Healthcare Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Days Sales Outstanding	Get a 7-Day Free Trial															44.98	45.98	45.46	39.06	46.72

Competitive Comparison of Fisher & Paykel Healthcare's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fisher & Paykel Healthcare's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's Days Sales Outstanding falls into.

Fisher & Paykel Healthcare Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Fisher & Paykel Healthcare's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (147.8	+	184.5)	/	2 )	/	1588.6	*	365
=	166.15					/	1588.6	*	365
=	38.17

Fisher & Paykel Healthcare's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding (Q: Sep. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )	/	Revenue (A: Sep. 2023 )	*	Days in Period
=	( (184.5	+	233.2)	/	2 )	/	815.8	*	365 / 2
=	208.85					/	815.8	*	365 / 2
=	46.72

Fisher & Paykel Healthcare (NZSE:FPH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Fisher & Paykel Healthcare Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

FSPKF:USA FPLB:Germany FPH:Australia

Address

15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013

Website

https://www.fphcare.com

Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.